|
|
BioPhytMol Statistics:
Table - 1: General information about BioPhytMol
| Total entries | Unique plant families | Unique species | Number of phytomolecules | Type of target bacteria |
| 2582 | 188 | 808 | 633 | 25 |
Table - 2: Statistics of molecular properties of BioPhytMol molecules
| Descriptors | Mean | Min | Max
| | Molecular Weight | 356.93 | 74.08 | 2094.44
| | XLogP | 5.01 | -2.6 | 31.91
| | H_bond acceptors | 4.05 | 0 | 45
| | H_bond donors | 1.40 | 0 | 17
| | No. of rotatable bonds | 4.97 | 0 | 48
| | Topological Polar Surface Area | 65.12 | 0 | 649.39
| | No. of rings | 3.06 | 0 | 10
|
Figure- 1: Molecular weight distribution of BioPhytMol compounds
[Top]
Figure- 2: Hydrogen bond donor distribution of BioPhytMol compounds
[Top]
Figure- 3: Hydrogen bond acceptor distribution of BioPhytMol compounds
[Top]
Figure- 4: XLogP distribution of BioPhytMol compounds
[Top]
Figure- 5: No. of rotatable bonds distribution of BioPhytMol compounds
[Top]
Figure- 6: Polar surface area distribution of BioPhytMol compounds
[Top]
Figure- 7: Molecular weight distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 8: Hydrogen bond donor distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 9: Hydrogen bond acceptor distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 10: XLogP distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 11: Number of rotatable bonds distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 12:Polar surface area distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs
[Top]
Figure- 13: Distribution of BioPhytMol compounds against various Mycobacterial Species
[Top]
| |
